The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Jun 2024)
Editorial: Checkpoint inhibition in hematologic malignancies
Jeffrey J. Pu,
Joseph J. Drabick,
Susan E. Prockop
Affiliations
Jeffrey J. Pu
VA Boston/Brigham & Women Hospital, Harvard Medical School, Boston, MA, United States
Joseph J. Drabick
Pennsylvania State University Hershey Cancer Institute, Hershey, PA, United States
Susan E. Prockop
Dana-Farber/Boston Children’s Hospital, Harvard Medical School, Boston, MA, United States
DOI
https://doi.org/10.3389/fonc.2024.1429854
Journal volume & issue
Vol. 14
Abstract
Read online
No abstracts available.
Keywords
immune checkpoint inhibiter
hypomethylation agent
hematological malignancy
PD-1/PDL-1
CTLA-4
leukemia
WeChat QR code
Close